144
Views
0
CrossRef citations to date
0
Altmetric
Review

Therapeutic Potential of Vitamin B1 Derivative Benfotiamine From Diabetes to COVID-19

ORCID Icon, , , , & ORCID Icon
Pages 809-826 | Received 24 Feb 2022, Accepted 12 Apr 2022, Published online: 10 May 2022

References

  • Whitfield KC , SmithTJ , RohnerF , WieringaFT , GreenTJ. Thiamine fortification strategies in low- and middle-income settings: a review. Ann. NY Acad. Sci.1498(1), 29–45 (2021).
  • Beltramo E , MazzeoA , PortaM. Thiamine and diabetes: back to the future?Acta Diabetol.58(11), 1433–1439 (2021).
  • Manzetti S , ZhangJ , vander Spoel D. Thiamin function, metabolism, uptake, and transport. Biochemistry53(5), 821–835 (2014).
  • Zhao N , ZhongC , WangYet al. Impaired hippocampal neurogenesis is involved in cognitive dysfunction induced by thiamine deficiency at early pre-pathological lesion stage. Neurobiol. Dis.29(2), 176–185 (2008).
  • Langlais PJ , ZhangSX , SavageLM. Neuropathology of thiamine deficiency: an update on the comparative analysis of human disorders and experimental models. Metab. Brain Dis.11(1), 19–37 (1996).
  • Polegato BF , PereiraAG , AzevedoPSet al. Role of thiamin in health and disease. Nutr. Clin. Pract.34(4), 558–564 (2019).
  • Lonsdale D . Thiamin. Adv. Food Nutr. Res.83, 1–56 (2018).
  • DiNicolantonio JJ , NiaziAK , LavieCJ , O'KeefeJH , VenturaHO. Thiamine supplementation for the treatment of heart failure: a review of the literature. Congest. Heart Fail.19(4), 214–222 (2013).
  • Cook CC . Prevention and treatment of Wernicke–Korsakoff syndrome. Alcohol Alcohol.35(1), 19–20 (2000).
  • Prakasha SR , MustafaAS , BaikunjeS , SubramanyamK. “Dry” and “wet” beriberi mimicking critical illness polyneuropathy. Ann. Indian Acad. Neurol.16(4), 687–689 (2013).
  • Bettendorff L . Update on thiamine triphosphorylated derivatives and metabolizing enzymatic complexes. Biomolecules11(11), 1645 (2021).
  • Bettendorff L . Thiamine. In: Basic Nutrition and Metabolism; Present Knowledge in Nutrition (11th Edition).MarriottB, BirtD, StallingV, YatesA ( Eds). Academic Press, MA, USA, 676 (2020).
  • Bettendorff L , WinsP. Thiamine derivatives in excitable tissues: metabolism, deficiency and neurodegenerative diseases. Recent Res. Devel. Neurochem. (2), 37–62 (1999).
  • Gangolf M , CzernieckiJ , RadermeckerMet al. Thiamine status in humans and content of phosphorylated thiamine derivatives in biopsies and cultured cells. PloS One5(10), e13616 (2010).
  • Sambon M , GorlovaA , DemelenneAet al. Dibenzoylthiamine has powerful antioxidant and anti-inflammatory properties in cultured cells and in mouse models of stress and neurodegeneration. Biomedicines8(9), 361 (2020).
  • Tylicki A , ŁotowskiZ , SiemieniukM , RatkiewiczA. Thiamine and selected thiamine antivitamins – biological activity and methods of synthesis. Biosci. Rep.38(1), BSR20171148 (2018).
  • Bitsch R , WolfM , MöllerJ , HeuzerothL , GrünekleeD. Bioavailability assessment of the lipophilic benfotiamine as compared to water-soluble thiamin derivative. Ann. Nutri. Metab.35(5), 292–296 (1991).
  • Lonsdale D . A review of the biochemistry, metabolism and clinical benefits of thiamin(e) and its derivatives. Evid. Based Complement. Alternat. Med.3, 49–59 (2006).
  • Greb A , BitschR. Comparative bioavailability of various thiamine derivatives after oral administration. Int. J. Clin. Pharmacol. Ther.36, 216–221 (1998).
  • Abudukelimu A , BarberisM , RedegeldFA , SahinN , WesterhoffHV. Predictable irreversible switching between acute and chronic inflammation. Front. Immunol.9, 1596 (2018).
  • Biswas SK . Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?Oxid. Med. Cell Longev.5698931http://doi.org/10.1155/2016/5698931 (2016).
  • de Andrade JAA , GayerCRM , NogueiraNPAet al. The effect of thiamine deficiency on inflammation, oxidative stress and cellular migration in an experimental model of sepsis. J. Inflamm. (Lond.)11, 11 (2014).
  • Donnino MW , AndersenLW , ChaseMet al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Crit. Care Med.44(2), 360–367 (2016).
  • Miyamoto Y , AsoS , IwagamiMet al. Association between IV thiamine and mortality in patients with septic shock: a nationwide observational study. Crit. Care Med.48(8), 1135–1139 (2020).
  • Yadav UC , SubramanyamS , RamanaKV. Prevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1. Invest. Ophthalmol. Vis. Sci.50(5), 2276–2282 (2009).
  • Bozic I , SavicD , LaketaDet al. Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia. PLoS One10(2), e0118372 (2015).
  • Yadav UC , KalariyaNM , SrivastavaSK , RamanaKV. Protective role of benfotiamine, a fat-soluble vitamin B1 analogue, in lipopolysaccharide-induced cytotoxic signals in murine macrophages. Free Radic. Biol. Med.48(10), 1423–1434 (2010).
  • Shoeb M , RamanaKV. Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages. Free Radic. Biol. Med.52(1), 182–190 (2012).
  • Ahmed LA , HassanOF , GalalO , MansourDF , El-KhatibA. Beneficial effects of benfotiamine, a NADPH oxidase inhibitor, in isoproterenol-induced myocardial infarction in rats. PLoS One15(5), e0232413 (2020).
  • Thakur KT , AlbaneseE , GiannakopoulosPet al. Neurological disorders. In: Mental, Neurological, and Substance Use Disorders: Disease Control Priorities (3rd Edition, Volume 4).PatelV, ChisholmD, DuaT, LaxminarayanR, Medina-MoraME ( Eds). The World Bank, DC, USA (2016).
  • Sengoku R . Aging and Alzheimer's disease pathology. Neuropathology40(1), 22–29 (2020).
  • Trist BG , HareDJ , DoubleKL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease. Aging Cell18(6), e13031 (2019).
  • Perez-Pineiro R , BjorndahlTC , BerjanskiiMVet al. The prion protein binds thiamine. FEBS J.278(21), 4002–4014 (2011).
  • Nakamura ZM , TatreauJR , RosensteinDL , ParkEM. Clinical characteristics and outcomes associated with high-dose intravenous thiamine administration in patients with encephalopathy. Psychosomatics59(4), 379–387 (2018).
  • Isen DR , KlineLB. Neuro-ophthalmic manifestations of Wernicke encephalopathy. Eye Brain12, 49–60 (2020).
  • Latt N , DoreG. Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders. Intern. Med. J.44(9), 911–915 (2014).
  • Sambon M , WinsP , BettendorffL. Neuroprotective effects of thiamine and precursors with higher bioavailability: focus on benfotiamine and dibenzoylthiamine. Int. J. Mol. Sci.22(11), 5418 (2021).
  • Manzardo AM , HeJ , PojeA , PenickEC , CampbellJ , ButlerMG. Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence. Drug Alcohol Depend.133(2), 562–570 (2013).
  • Ikeda K , LiuX , KidacKet al. Thiamine as a neuroprotective agent after cardiac arrest. Resuscitation105, 138–144 (2016).
  • Gibson GE , HirschJA , FonzettiP , JordanBD , CirioRT , ElderJ. Vitamin B1 (thiamine) and dementia. Ann. NY Acad. Sci.1367(1), 21–30 (2016).
  • Toledo Nunes P , VedderLC , DeakT , SavageLM. A pivotal role for thiamine deficiency in the expression of neuroinflammation markers in models of alcohol-related brain damage. Alcohol. Clin. Exp. Res.43(3), 425–438 (2019).
  • Smith TJ , JohnsonCR , KoshyRet al. Thiamine deficiency disorders: a clinical perspective. Ann. NY Acad. Sci.1498(1), 9–28 (2021).
  • Chou WP , ChangYH , LinHC , ChangYH , ChenYY , KoCH. Thiamine for preventing dementia development among patients with alcohol use disorder: a nationwide population-based cohort study. Clin. Nutr.38(3), 1269–1273 (2019).
  • Sheu KF , ClarkeDD , KimYT , BlassJP , HardingBJ , DeCiccoJ. Studies of transketolase abnormality in Alzheimer's disease. Arch. Neurol.45, 841–845 (1988).
  • Pan X , ChenZ , FeiGet al. Long-term improvement after benfotiamine administration in patients with Alzheimer's disease. Neurosci. Bull.32(6), 591–596 (2016).
  • Tapias V , JainuddinS , AhujaMet al. Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy. Hum. Mol. Genet.27(16), 2874–2892 (2018).
  • Vignisse J , SambonM , GorlovaAet al. Thiamine and benfotiamine prevent stress-induced suppression of hippocampal neurogenesis in mice exposed to predation without affecting brain thiamine diphosphate levels. Mol. Cell. Neurosci.82, 126–136 (2017).
  • Sambon M , NappA , DemelenneAet al. Thiamine and benfotiamine protect neuroblastoma cells against paraquat and β-amyloid toxicity by a coenzyme-independent mechanism. Heliyon5(5), e01710 (2019).
  • Markova N , BazhenovaN , AnthonyDCet al. Thiamine and benfotiamine improve cognition and ameliorate GSK-3β-associated stress-induced behaviours in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry75, 148–156 (2017).
  • Gorlova A , PavlovD , AnthonyDCet al. Thiamine and benfotiamine counteract ultrasound-induced aggression, normalize AMPA receptor expression and plasticity markers, and reduce oxidative stress in mice. Neuropharmacology156, 107543 (2019).
  • Gibson GE , LuchsingerJA , CirioRet al. Benfotiamine and cognitive decline in Alzheimer's disease: results of a randomized placebo-controlled phase IIa clinical trial. J. Alzheimers Dis.78(3), 989–1010 (2020).
  • Sang S , PanX , ChenZet al. Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer's disease, whereas amyloid deposition does not. Alzheimers Res Ther.10(1), 26 (2018).
  • Pacal L , KuricovaK , KankovaK. Evidence for altered thiamine metabolism in diabetes: is there a potential to oppose gluco- and lipotoxicity by rational supplementation?World J. Diabetes5(3), 288–295 (2014).
  • Forbes JM , CooperME. Mechanisms of diabetic complications. Physiol. Rev.93(1), 137–188 (2013).
  • Srivastava SK , RamanaKV , BhatnagarA. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr. Rev.26(3), 380–392 (2005).
  • Head KA . Peripheral neuropathy: pathogenic mechanisms and alternative therapies. Altern. Med. Rev.11(4), 294–329 (2006).
  • Tarr JM , KaulK , ChopraM , KohnerEM , ChibberR. Pathophysiology of diabetic retinopathy. Int. Sch. Res. Notices2013, 343560 (2013).
  • Song J , YangX , YanLJ. Role of pseudohypoxia in the pathogenesis of Type 2 diabetes. Hypoxia (Auckl.)7, 33–40 (2019).
  • Aragno M , MastrocolaR. Dietary sugars and endogenous formation of advanced glycation endproducts: emerging mechanisms of disease. Nutrients9(4), 385 (2017).
  • Choei H , SasakiN , TakeuchiMet al. Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease. Acta Neuropathol.108(3), 189–193 (2004).
  • González I , MoralesMA , RojasA. Polyphenols and AGEs/RAGE axis. Trends and challenges. Food Res. Int.129, 108843 (2020).
  • Koya D , KingGL. Protein kinase C activation and the development of diabetic complications. Diabetes47(6), 859–866 (1998).
  • Tabit CE , ShenoudaSM , HolbrookMet al. Protein kinase C-β contributes to impaired endothelial insulin signaling in humans with diabetes mellitus. Circulation127(1), 86–95 (2013).
  • Elmouelhi N , AichU , ParuchuriVDet al. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery. J. Med. Chem.52(8), 2515–2530 (2009).
  • Du XL , EdelsteinD , RossettiLet al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl Acad. Sci. USA97, 12222–12226 (2000).
  • Nishikawa T , EdelsteinD , DuXLet al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature404, 787–790 (2000).
  • Rosner EA , StrezleckiKD , ClarkJA , Lieh-LaiM. Low thiamine levels in children with Type 1 diabetes and diabetic ketoacidosis: a pilot study. Pediatr. Crit. Care Med.16(2), 114–118 (2015).
  • Anwar A , AzmiAM , SiddiquiJet al. Thiamine level in Type I and Type II diabetes mellitus patients: a comparative study focusing on hematological and biochemical evaluations. Cureus12(5), e8027 (2020).
  • Hiffler L , RakotoambininaB , LaffertyN , GarciaDM. Thiamine deficiency in tropical pediatrics: new insights into a neglected but metabolic challenge. Front. Nutr.3, 16 (2016).
  • Beltramo E , BerroneE , TaralloSet al. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications. Acta Diabetol.45, 131 (2008).
  • Hammes HP , DuX , EdelsteinDet al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med.9(3), 294–299 (2003).
  • Feldman EL , CallaghanBC , Pop-BusuiRet al. Diabetic neuropathy. Nat. Rev. Dis. Primers5, 41 (2019).
  • Yang H , SloanG , YeYet al. New perspective in diabetic neuropathy: from the periphery to the brain, a call for early detection and precision medicine. Front. Endocrinol.10, 3389 (2020).
  • Albers JW , Pop-BusuiR. Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr. Neurol. Neurosci. Rep.14, 473 (2014).
  • Singh R , KishoreL , KaurN. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol. Res.80, 21–35 (2014).
  • Vafadar GL , BehnamRM , MatinMM , Mahdavi-ShahriN. Benfotiamine reduced collagen IV contents of sciatic nerve in hyperglycemic rats. J. Diabetes Metab. Disord.20(1), 21–30 (2021).
  • Gadau S , EmanueliC , Van LinthoutSet al. Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis. Diabetologia49(2), 405–420 (2006).
  • Sánchez-Ramírez GM , Caram-SalasNL , Rocha-GonzálezHIet al. Benfotiamine relieves inflammatory and neuropathic pain in rats. Eur. J. Pharmacol.530(1–2), 48–53 (2006).
  • Wu S , RenJ. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha. Neurosci. Lett.394(2), 158–162 (2006).
  • Stracke H , HammesHP , WerkmannDet al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp. Clin. Endocrinol. Diabetes109(6), 330–336 (2001).
  • Karaganis S , SongXJ. B vitamins as a treatment for diabetic pain and neuropathy. J. Clin. Pharm. Ther.46(5), 1199–1212 (2021).
  • Haupt E , LedermannH , KopckeW. Benfotiamine in the treatment of diabetic polyneuropathy – a three-week randomized, controlled pilot study (BEDIP study). Int. J. Clin. Pharmacol. Ther.43(2), 71–77 (2005).
  • Stracke H , GausW , AchenbachU , FederlinK , BretzelRG. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp. Clin. Endocrinol. Diabetes116(10), 600–605 (2008).
  • Fraser DA , DiepLM , HovdenIAet al. The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with Type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial. Diabetes Care35(5), 1095–1097 (2012).
  • Lechner J , O'LearyOE , StittAW. The pathology associated with diabetic retinopathy. Vision Res.139, 7–14 (2017).
  • Beltramo E , NizheradzeK , BerroneE , TaralloS , PortaM. Thiamine and benfotiamine prevent apoptosis induced by high glucose-conditioned extracellular matrix in human retinal pericytes. Diabetes Metab. Res. Rev.25(7), 647–656 (2009).
  • Qi C , MaoX , ZhangZ , WuH. Classification and differential diagnosis of diabetic nephropathy. J. Diabetes Res.2017, 8637138 (2017).
  • Sawaf H , ThomasG , TaliercioJJ , NakhoulG , VachharajaniTJ , MehdiA. Therapeutic advances in diabetic nephropathy. J. Clin. Med.11(2), 378 (2022).
  • Babaei-Jadidi R , KarachaliasN , AhmedN , BattahS , ThornalleyPJ. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes52(8), 2110–2120 (2003).
  • Müller-Krebs S , NissleK , TsobaneliJet al. Effect of benfotiamine in podocyte damage induced by peritoneal dialysis fluid. Front. Med. (Lausanne)2, 10 (2015).
  • Karachalias N , Babaei-JadidiR , RabbaniN , ThornalleyPJ. Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes. Diabetologia53(7), 1506–1516 (2010).
  • Alkhalaf A , KloosterA , van OeverenWet al. A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy. Diabetes Care33(7), 1598–1601 (2010).
  • Alkhalaf A , KleefstraN , GroenierKHet al. Effect of benfotiamine on advanced glycation end products and markers of endothelial dysfunction and inflammation in diabetic nephropathy. PLoS One7(7), e40427 (2012).
  • Ustuner MA , KamanD , ColakogluN. Effects of benfotiamine and coenzyme Q10 on kidney damage induced gentamicin. Tissue Cell49(6), 691–696 (2017).
  • Kihm LP , Müller-KrebsS , KleinJet al. Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis. J. Am. Soc. Nephrol.22(5), 914–926 (2011).
  • Jovic TH , AliSR , IbrahimNet al. Could vitamins help in the fight against COVID-19? Nutrients 12(9), 2550 (2020).
  • Akashi Y , SuzukiH , KanemotoKet al. Thiamine concentrations in newly hospitalized elderly patients with infectious diseases at a community hospital in Japan. J. Nutr. Sci. Vitaminol. (Tokyo)64(3), 209–214 (2018).
  • Arici C , TebaldiA , QuinzanGP , MaggioloF , RipamontiD , SuterF. Severe lactic acidosis and thiamine administration in an HIV-infected patient on HAART. Int. J. STD AIDS12(6), 407–409 (2001).
  • Shoji S , FuruishiK , OgataAet al. An allosteric drug, o,o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B. Biochem. Biophys. Res. Commun.249(3), 745–753 (1998).
  • L Ng Kv , NguyễnLT. The role of thiamine in HIV infection. Int. J. Infect. Dis.17(4), e221–e227 (2013).
  • Tanaka T , SohmiyaK , KonoTet al. Thiamine attenuates the hypertension and metabolic abnormalities in CD36-defective SHR: uncoupling of glucose oxidation from cellular entry accompanied with enhanced protein O-GlcNAcylation in CD36 deficiency. Mol. Cell. Biochem.299(1–2), 23–35 (2007).
  • Sriram K , ManzanaresW , JosephK. Thiamine in nutrition therapy. Nutr. Clin. Pract.27(1), 41–50 (2012).
  • Al Sulaiman K , AljuhaniO , AlDossari Met al. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study. Crit. Care25(1), 223 (2021).
  • Branco de Oliveira MV , IrikuraS , LourençoFHBet al. Encephalopathy responsive to thiamine in severe COVID-19 patients. Brain Behav. Immun. Health14, 100252 (2021).
  • Vatsalya V , LiF , FrimodigJC , GalaKSet al. Therapeutic prospects for Th-17 cell immune storm syndrome and neurological symptoms in COVID-19: thiamine efficacy and safety, in-vitro evidence and pharmacokinetic profile. Front. Pharmacol.11, 598128 (2021).
  • Kousar S , SheikhMA , AsgharM. Antiglycation activity of thiamin-HCl and benfotiamine in diabetic condition. J. Pak. Med. Assoc.62(10), 1033–1038 (2012).
  • Bondar A , PopaAR , PapanasNet al. Diabetic neuropathy: a narrative review of risk factors, classification, screening and current pathogenic treatment options (review). Exp. Ther. Med.22(1), 690 (2021).
  • Sheng L , CaoW , LinPet al. Safety, tolerability and pharmacokinetics of single and multiple ascending doses of benfotiamine in healthy subjects. Drug Des. Devel. Ther.15, 1101–1110http://doi.org/10.2147/DDDT.S296197 (2021).
  • Volvert ML , SeyenS , PietteMet al. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. BMC Pharmacol.8http://doi.org/10.1186/1471-2210-8-10, 10 (2008).
  • Biró A , MarkovicsA , FazekasMÉet al. Allithiamine alleviates hyperglycaemia-induced endothelial dysfunction. Nutrients12(6), 1690 (2020).
  • Choi EJ , JeonCH , ParkDH , KwonTH. Allithiamine exerts therapeutic effects on sepsis by modulating metabolic flux during dendritic cell activation. Mol. Cells43(11), 964–973 (2020).
  • Van Reeth O . Pharmacologic and therapeutic features of sulbutiamine. Drugs Today35, 187–192 (1999).
  • Loo H , PoirierMF , OllatHet al. Effects of sulbutiamine (Arcalion 200) on psycho-behavioral inhibition in major depressive episodes. Encephale26(2), 70–75 (2000).
  • Shinozaki H . Cardiac action of thiamine derivatives in guinea pig atria. J. Nutr. Sci. Vitaminol.22, 29–34 (1976).
  • Do JY , KimJ , KimMJet al. Fursultiamine alleviates choroidal neovascularization by suppressing inflammation and metabolic reprogramming. Invest. Ophthalmol. Vis. Sci.61(12), 24 (2020).
  • Bönhof GJ , SipolaG , StromAet al. BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with Type 2 diabetes with symptomatic polyneuropathy. BMJ Open12(2), e057142 (2022).
  • Wilson RB . Pathophysiology, prevention, and treatment of beriberi after gastric surgery. Nutr. Rev.78(12), 1015–1029 (2020).
  • Manzardo AM , PendletonT , PojeA , PenickEC , ButlerMG. Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity. Drug Alcohol Depend.152, 257–263 (2015).
  • Jonus HC , ByrnesCC , KimJet al. Thiamine mimetics sulbutiamine and benfotiamine as a nutraceutical approach to anticancer therapy. Biomed. Pharmacother.121, 109648 (2020).
  • Iimura Y , AndohS , KawamataTet al. Thiamine deficiency and neurological symptoms in patients with hematological cancer receiving chemotherapy: a retrospective analysis. J. Neurosci. Rural Pract.12(4), 726–732 (2021).
  • Iimura Y , KurokawaT , AndohSet al. Association between thiamine decrease and neuropsychiatric symptoms in gastrointestinal and hematological cancer patients receiving chemotherapy. Biomed. Pharmacother.141, 111929 (2021).
  • Peterson CT , RodionovDA , OstermanAL , PetersonSN. B vitamins and their role in immune regulation and cancer. Nutrients12(11), 3380 (2020).
  • Sabui S , RomeroJM , SaidHM. Developmental maturation of the colonic uptake process of the microbiota-generated thiamin pyrophosphate. Am. J. Physiol. Gastrointest. Liver Physiol.320(5), G829–G835 (2021).
  • Hung WW , PengP , TsaiYCet al. Gut microbiota compositions and metabolic functions in Type 2 diabetes differ with glycemic durability to metformin monotherapy. Diabetes Res. Clin. Pract. (174), 108731 doi:10.1016/j.diabres.2021.108731 (2021).
  • Park SY , FaraciG , NandaSet al. Gut microbiome in people living with HIV is associated with impaired thiamine and folate syntheses. Microb. Pathog.160, 105209 (2021).
  • Shakoor H , FeehanJ , MikkelsenKet al. Be well: a potential role for vitamin B in COVID-19. Maturitas144, 108–111 (2021).
  • Ranjbar M , KarbalaieNiya MH , RohamMet al. Serum level of vitamin D is associated with COVID-19 mortality rate in hospitalized patients. J. Res. Med. Sci.26, 112 (2021).
  • Jaun F , BoesingM , Lüthi-CorridoriGet al. High-dose vitamin D substitution in patients with COVID-19: study protocol for a randomized, double-blind, placebo-controlled, multi-center study-vitcov trial. Trials23(1), 114 (2022).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.